EA199800146A1 - USING IPPRIFLAVON TO REDUCE THE CD8 + CELL NUMBER - Google Patents

USING IPPRIFLAVON TO REDUCE THE CD8 + CELL NUMBER

Info

Publication number
EA199800146A1
EA199800146A1 EA199800146A EA199800146A EA199800146A1 EA 199800146 A1 EA199800146 A1 EA 199800146A1 EA 199800146 A EA199800146 A EA 199800146A EA 199800146 A EA199800146 A EA 199800146A EA 199800146 A1 EA199800146 A1 EA 199800146A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
ippriflavon
reduce
cell number
isoflavone
Prior art date
Application number
EA199800146A
Other languages
Russian (ru)
Inventor
Аттила Б.Ковач
Петер Араньи
Терезия Керепеши
Дьёрдь Вараи
Аттила Тар
Original Assignee
Чиноин Дьёдьсер Еш Ведьесети Термекек Дьяра Рт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Чиноин Дьёдьсер Еш Ведьесети Термекек Дьяра Рт filed Critical Чиноин Дьёдьсер Еш Ведьесети Термекек Дьяра Рт
Publication of EA199800146A1 publication Critical patent/EA199800146A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Настоящее изобретение относится к фармацевтическим композициям, которые могут использоваться для понижения числа CD8+ клеток, содержащим в качестве активного ингредиента 7-изопропоксиизофлавон в смеси с подходящими инертными, твердыми или жидкими носителями и, выборочно, с обычными терапевтическими добавками и вспомогательными агентами. Фармацевтические композиции в соответствии с изобретением готовят известными способами, и они являются подходящими для лечения человека или животных, находящихся в состоянии, когда желательна селективная супрессия CD8+ лимфоцитов.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention relates to pharmaceutical compositions that can be used to lower the number of CD8 + cells, containing 7-isopropoxy-isoflavone as an active ingredient in a mixture with suitable inert, solid or liquid carriers and, optionally, with conventional therapeutic additives and auxiliary agents. Pharmaceutical compositions in accordance with the invention are prepared by known methods, and they are suitable for treating humans or animals in a state where selective suppression of CD8 + lymphocytes is desired. The international application was published along with an international search report.

EA199800146A 1995-07-21 1996-07-16 USING IPPRIFLAVON TO REDUCE THE CD8 + CELL NUMBER EA199800146A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication
PCT/HU1996/000038 WO1997003664A1 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells

Publications (1)

Publication Number Publication Date
EA199800146A1 true EA199800146A1 (en) 1998-08-27

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800146A EA199800146A1 (en) 1995-07-21 1996-07-16 USING IPPRIFLAVON TO REDUCE THE CD8 + CELL NUMBER

Country Status (22)

Country Link
EP (1) EP0841915A1 (en)
JP (1) JP2001503371A (en)
KR (1) KR19990028933A (en)
CN (1) CN1191483A (en)
AR (1) AR002905A1 (en)
AU (1) AU6367096A (en)
BG (1) BG102182A (en)
BR (1) BR9610187A (en)
CA (1) CA2227421A1 (en)
CZ (1) CZ2798A3 (en)
EA (1) EA199800146A1 (en)
EE (1) EE9800020A (en)
HR (1) HRP960345A2 (en)
HU (1) HU9502198D0 (en)
IL (1) IL122751A0 (en)
MX (1) MX9800603A (en)
NO (1) NO980127D0 (en)
PL (1) PL324460A1 (en)
SK (1) SK3298A3 (en)
WO (1) WO1997003664A1 (en)
YU (1) YU42796A (en)
ZA (1) ZA966079B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (en) * 1990-03-23 1993-12-29 Chiesi Farma Spa PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
AR002905A1 (en) 1998-04-29
EE9800020A (en) 1998-08-17
SK3298A3 (en) 1998-07-08
KR19990028933A (en) 1999-04-15
AU6367096A (en) 1997-02-18
EP0841915A1 (en) 1998-05-20
CZ2798A3 (en) 1998-06-17
CA2227421A1 (en) 1997-02-06
MX9800603A (en) 1998-04-30
BG102182A (en) 1998-08-31
IL122751A0 (en) 1998-08-16
NO980127L (en) 1998-01-12
JP2001503371A (en) 2001-03-13
HU9502198D0 (en) 1995-09-28
PL324460A1 (en) 1998-05-25
ZA966079B (en) 1998-01-19
BR9610187A (en) 1998-07-28
YU42796A (en) 1999-03-04
WO1997003664A1 (en) 1997-02-06
NO980127D0 (en) 1998-01-12
HRP960345A2 (en) 1998-02-28
CN1191483A (en) 1998-08-26
WO1997003664A8 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
SE8702907D0 (en) STABLE PHARMACEUTICAL PREPARATION CONTAINING GRANULOCYTE COLONY STIMULATING FACTOR AND PROCESS FOR PRODUCING THE SAME
EA200100103A1 (en) CELL ADHESION INHIBITORS
EA199800943A1 (en) UREA DERIVATIVES AND THEIR USE AS INHIBITORS INOSINE-5`-MONO-PHOSPHATE-DEHYDROGENASE INHIBITORS
IL74535A (en) Antiviral pharmaceutical compositions containing lidocaine,prilocaine,etidocaine,mepivacaine or bupivacaine and method for the preparation thereof
DK0735890T3 (en) Mixtures of 2 ', 3'-dideoxyinosine and hydroxycarbamide to inhibit retroviral spread
KR900018098A (en) Pyridone Carboxylic Acids and Antibacterials
TW282393B (en)
RU94041836A (en) Derivatives of amidine, mixture of their isomers or individual isomers and their salts, pharmaceutical composition exhibiting antagonistic activity with respect to leukotriene b4 activity
ATE215827T1 (en) IMMUNOLOGICAL ACTIVITY OF RHAMNOLIPIDS
ZA83628B (en) Pharmacologically active pyrazolo/4,3-/pyridines
DE3862337D1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING ESTER OR AMIDE AS ACTIVE INGREDIENTS.
DE3172298D1 (en) Pharmaceutical compositions
EA199900876A1 (en) PHARMACEUTICAL COMPOSITIONS AGAINST COUGH
IE861623L (en) Biologically active copolymer composition
MD1688F2 (en) Benzothiophene, benzofuran and indolethiazepinons, oxazepinons and diazepinons, pharmaceutical composition, method of inhibiting the leucocytes adherence to the endothelial cells for inflammatory diseases treatment and method of treatment of the mammals affected by the HIV infection
ES2134237T3 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING URSODESOXICOLICO ACID.
ES2002083A6 (en) Pyroglutamide derivatives
BE887566A (en) NOVEL 2-AMINO-3- (ALPHA-HEDROXYBENZYL) -PHENYLACETICS AND THEIR ESTERS AND AMIDES, ESPECIALLY USEFUL AS ANTI-INFLAMMATORY AGENTS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2420344A1 (en) NEW OXIME-ETHERS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
EA199800146A1 (en) USING IPPRIFLAVON TO REDUCE THE CD8 + CELL NUMBER
KR880007068A (en) Use of 13-cis retinoic acid
KR850700108A (en) Anti-tumor pharmaceutical composition and preparation method thereof
ES8406468A1 (en) Substituted tert. butanol derivatives, method for their preparation and antimycotic agents containing them.
FR2384791A1 (en) NEW EVERNINOMICINE DERIVATIVES, THEIR PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAID DERIVATIVES
DK381983A (en) METHOD FOR PREPARING SPIRO (2H-1,4-BENZODIOXEPIN-3 (5H) 4'-PIPERIDINE AND -3'-PYRROLIDE COMPOUNDS)